17:04 EDT Orchard Therapeutics files to sell 20.825M ADSs for holders
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ORTX:
- Orchard Therapeutics completes submission of BLA for OTL-200 in MLD to U.S. FDA
- Orchard Therapeutics Completes Submission of Biologics License Application for OTL-200 in MLD to U.S. FDA
- Orchard Therapeutics supports enactment of Newborn Metabolic Screening Act
- Orchard Therapeutics Strongly Supports Enactment of Newborn Metabolic Screening Act in Illinois, Adding Metachromatic Leukodystrophy to Statewide Panel
- Orchard Therapeutics to Webcast Conference Call of Second Quarter 2023 Financial Results
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue